Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors

被引：26

作者：

Zamecnik, Michal ^{[1
,2
]}

Rychnovsky, Jiri ^{[1
]}

Syrovatka, Jakub ^{[3
]}

机构：

[1] Agel Labs As, Dept Pathol, Novy Jicin, Czech Republic

[2] Medirex Grp Acad, Bratislava, Slovakia

[3] Agel Hosp, Dept Otorhinolaryngol Head & Neck Surg, Novy Jicin, Czech Republic

来源：

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2018年 / 26卷 / 03期

关键词：

SMARCB1 (INI1) deficient carcinoma; sinonasal carcinoma; yolk sac tumor; gonadal mixed germ cell tumor; ENDODERMAL SINUS TUMOR; PARA-NASAL SINUSES; MALIGNANT TERATOMA; HYPERCALCEMIC TYPE; NEOPLASIA; FEATURES;

D O I：

10.1177/1066896917741549

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

SMARCB1 (INI1) deficient sinonasal carcinoma is a recently recognized entity with wide histomorphologic spectrum. We present a case of this carcinoma that contained, in addition to a common morphology, scattered foci of yolk sac tumor differentiation. The tumor occurred in paranasal sinuses in a 44-year-old woman. Immunohistochemically, it was diffusely negative for INI1, whereas an expression of yolk sac tumor markers (-fetoprotein, glypican-3, CDX2) was limited to the yolk sac tumor component. For comparison with the present case, we performed INI1 immunostaining on a series of 11 gonadal germ cell tumors with yolk sac tumor differentiation. All of these cases showed strong and diffuse expression of INI1, in contrast with the present sinonasal tumor. Our findings expand the morphologic spectrum of SMARCB1 (INI1) deficient sinonasal carcinoma. In addition, we show preliminarily that gonadal germ cell tumors with yolk sac tumor differentiation are not SMARCB1/INI1-deficient.

引用

页码：245 / 249

页数：5

共 50 条

[41] SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features
Ayyanar, Pavithra
Mishra, Pritinanda
Preetam, Chappity
Adhya, Amit Kumar
HEAD & NECK PATHOLOGY, 2021, 15 (02): : 555 - 565
[42] Loss of SMARCB1/INI1 Immunoexpression in Chordoid Meningiomas
Malgulwar, Prit B.
Kakkar, Aanchal
Sharma, Mehar C.
Ghosh, Ranajoy
Pathak, Pankaj
Sarkar, Chitra
Suri, Vaishali
Singh, Manmohan
Kale, Shashank S.
Faruq, Mohammed
NEUROLOGY INDIA, 2019, 67 (06) : 1492 - 1497
[43] INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland
Srinivasan, Archana
Tuluc, Madalina
Jordan, Arthur J.
Curry, Joseph M.
Bilyk, Jurij R.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 35 (02): : E41 - E43
[44] SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features
Pavithra Ayyanar
Pritinanda Mishra
Chappity Preetam
Amit Kumar Adhya
Head and Neck Pathology, 2021, 15 : 555 - 565
[45] Germline mutation of INI1/SMARCB1 in familial schwannomatosis
Hulsebos, Theo J. M.
Plomp, Astrid S.
Wolterman, Ruud A.
Robanus-Maandag, Els C.
Baas, Frank
Wesseling, Pieter
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (04) : 805 - 810
[46] Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis
Boyd, C.
Smith, M. J.
Kluwe, L.
Balogh, A.
MacCollin, M.
Plotkin, S. R.
CLINICAL GENETICS, 2008, 74 (04) : 358 - 366
[47] The tumor suppressor gene hSNF5/INI1 (SMARCB1)
Soussi, T
BULLETIN DU CANCER, 2000, 87 (04) : 295 - 296
[48] Spectrum of SMARCB1/INI1 Mutations in Familial and Sporadic Rhabdoid Tumors
Eaton, Katherine W.
Tooke, Laura S.
Wainwright, Luanne M.
Judkins, Alexander R.
Biegel, Jaclyn A.
PEDIATRIC BLOOD & CANCER, 2011, 56 (01) : 7 - 15
[49] INI1 (SMARCB1) deletion of lung cancer: a case report and literature review
Hong-Yan Ma
Shuai Shi
Yin Zhou Sang
Jie Sun
Xing-guang Wang
Zhi-Gang Zhang
Egyptian Journal of Medical Human Genetics, 25 (1)
[50] Loss of SMARCB1/INI1 Expression in Pediatric Poorly Differentiated Chordomas
Clark, L.
Gokden, M.
Saad, A. G.
LABORATORY INVESTIGATION, 2012, 92 : 429A - 429A

← 1 2 3 4 5 →